Cargando…
Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications(,)
Coronaviruses disease 2019 (COVID-19) is the most crucial threat, the world has ever witnessed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of this disease pandemic. The World Health Organization has confirmed the continuing epidemic as a worldwide public heal...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906517/ https://www.ncbi.nlm.nih.gov/pubmed/33640363 http://dx.doi.org/10.1016/j.amjms.2021.02.019 |
_version_ | 1783655305597419520 |
---|---|
author | Mehta, Piyush P. Dhapte-Pawar, Vividha S. |
author_facet | Mehta, Piyush P. Dhapte-Pawar, Vividha S. |
author_sort | Mehta, Piyush P. |
collection | PubMed |
description | Coronaviruses disease 2019 (COVID-19) is the most crucial threat, the world has ever witnessed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of this disease pandemic. The World Health Organization has confirmed the continuing epidemic as a worldwide public health crisis. Presently, the research on COVID-19 is even in the primitive stage. Studies on unveiling the natural route of COVID-19 infection and related pathophysiology, the biology of pulmonary airways pose a more rational restorative approach in the management of COVID-19. Thus, based on the existing facts, we methodically reviewed the efforts put forth by various research institutes, pharmaceutical companies and biotechnology firms in pulmonary delivery to prevent and control the COVID-19. This article would be valuable for the healthcare community, which is efficiently dealing with the SARS-CoV-2 crisis. |
format | Online Article Text |
id | pubmed-7906517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Southern Society for Clinical Investigation. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79065172021-02-26 Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications(,) Mehta, Piyush P. Dhapte-Pawar, Vividha S. Am J Med Sci Review Article Coronaviruses disease 2019 (COVID-19) is the most crucial threat, the world has ever witnessed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of this disease pandemic. The World Health Organization has confirmed the continuing epidemic as a worldwide public health crisis. Presently, the research on COVID-19 is even in the primitive stage. Studies on unveiling the natural route of COVID-19 infection and related pathophysiology, the biology of pulmonary airways pose a more rational restorative approach in the management of COVID-19. Thus, based on the existing facts, we methodically reviewed the efforts put forth by various research institutes, pharmaceutical companies and biotechnology firms in pulmonary delivery to prevent and control the COVID-19. This article would be valuable for the healthcare community, which is efficiently dealing with the SARS-CoV-2 crisis. Southern Society for Clinical Investigation. Published by Elsevier Inc. 2021-05 2021-02-25 /pmc/articles/PMC7906517/ /pubmed/33640363 http://dx.doi.org/10.1016/j.amjms.2021.02.019 Text en © 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Article Mehta, Piyush P. Dhapte-Pawar, Vividha S. Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications(,) |
title | Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications(,) |
title_full | Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications(,) |
title_fullStr | Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications(,) |
title_full_unstemmed | Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications(,) |
title_short | Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications(,) |
title_sort | novel and evolving therapies for covid-19 related pulmonary complications(,) |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906517/ https://www.ncbi.nlm.nih.gov/pubmed/33640363 http://dx.doi.org/10.1016/j.amjms.2021.02.019 |
work_keys_str_mv | AT mehtapiyushp novelandevolvingtherapiesforcovid19relatedpulmonarycomplications AT dhaptepawarvividhas novelandevolvingtherapiesforcovid19relatedpulmonarycomplications |